The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This stock page is the Follow view. The Build view lets your agent query CFRX owners, fund changes, insider filings, and source links through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/CFRX"
Use Arkolith to show who owns CFRX, which funds added or reduced it, and which SEC filings prove each claim.
Not held in any tracked 13F filing yet.
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Feb 14, 2023 | Messinger Michael | Chief Financial Officer | Grant (A) | 25K | $126K |
| May 17, 2022 | Aklog Lishan | Director | Grant (A) | 42K | $141K |
| May 17, 2022 | BARER SOL J | Director | Grant (A) | 42K | $141K |
| May 17, 2022 | GILMAN STEVEN C | Director | Grant (A) | 42K | $141K |
| May 17, 2022 | Low David N. | Director | Grant (A) | 42K | $141K |
| May 17, 2022 | OTTO MICHAEL J. | Director | Grant (A) | 42K | $141K |
| May 17, 2022 | Sucoff Cary | Director | Grant (A) | 42K | $141K |
| May 17, 2022 | Barlow Jane F | Director | Grant (A) | 42K | $141K |
| Feb 15, 2022 | Bogdanos Natalie | General Counsel | Grant (A) | 125K | $416K |
| Feb 15, 2022 | Cassino Cara M | Chief Medical Officer | Grant (A) | 160K | $533K |
| Feb 15, 2022 | Messinger Michael | Chief Financial Officer | Grant (A) | 165K | $549K |
| Feb 15, 2022 | Pomerantz Roger | Chief Executive Officer, Director | Grant (A) | 500K | $1.7M |
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CFRX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.